Vol. 39 No. 3 (2022): JUNIO
Original Article

COVID 19 infection: age-stratified population-based cohort seroepidemiological study in Asunción and Central

Águeda Cabello
Ministerio de Salud Pública y Bienestar Social. Dirección General de Vigilancia de la Salud
Margarita Samudio
Universidad del Pacífico
Bio
Guillermo Sequera
Ministerio de Salud Pública y Bienestar Social. Dirección General de Vigilancia de la Salud
Sandra Ocampos
Ministerio de Salud Pública y Bienestar Social. Dirección General de Vigilancia de la Salud
Rosa Galeano
Ministerio de Salud Pública y Bienestar Social. Dirección General de Vigilancia de la Salud
Cynthia Vázquez
Ministerio de Salud Pública y Bienestar Social. Laboratorio Central de Salud Pública

Published 2022-08-02

How to Cite

1.
Cabello Águeda, Samudio M, Sequera G, Ocampos S, Galeano R, Vázquez C. COVID 19 infection: age-stratified population-based cohort seroepidemiological study in Asunción and Central. Rev. Chilena. Infectol. [Internet]. 2022 Aug. 2 [cited 2025 Dec. 31];39(3). Available from: https://www.revinf.cl/index.php/revinf/article/view/1375

Abstract

Background: COVID-19, caused by the severe acute respiratory syndrome virus type-2 (SARS-CoV-2), was declared a pandemic in March 2020. Seroprevalence studies are useful to estimate the proportion of the population previously infected, quantify the magnitude of transmission, estimate the fatality rate, evaluate the effect of interventions, and estimate the degree of immunity of the population. Aim:  To determine the extension of the infection and the cumulative incidence of age-specific infection, determined by seropositivity in the population of the sanitary regions of Asunción and the Central Department of Paraguay. Methods: Population-based cohort study. In Asunción 126 households and in the Central Department 609 were surveyed between December 2020 to March 2021. Three visits were made to the selected households. Results: The testing rate was 66.6%, 1,699 people (324 in Asunción and 1,375 in Central) of the 2,553 people registered. In the first, second and third rounds, seroprevalences were 15.5%, 15.4% and 14.3% in Asunción, respectively; in Central 23.1%, 27.8% and 26.9%, respectively. There was a seroconversion between the first and second rounds of 5.9%, and in the third round 6.5%; the accumulated global seroprevalence was 26.9% (95% CI: 24.8-19.1); in Asunción 23.1% (95% CI: 18.9-28.0) and in Central 27.8% (95% CI: 25.5-30.2). 8.5% of the participants reported symptoms; of them, 54.2% had positive serology. Conclusion: The sero-prevalence was high with a low proportion of people with symptoms.